Introduction
============

Vital dyes have significantly improved the success of vitreoretinal surgeries by enabling the visualization of preretinal tissues and membranes.[@b1-opth-10-1435],[@b2-opth-10-1435] Currently, the dyes such as Brilliant Blue G (BBG, Brilliant Peel), patent blue V (Blueron), indocyanine green (ICG), and trypan blue (TB) can be applied during pars plana vitrectomy for macular diseases, including macular holes, epiretinal membranes, and tractional (diabetic) macula. However, numerous studies have demonstrated adverse effects, such as toxicity in the retina, alterations in the retinal pigment epithelial (RPE) cells, and a reduced visual acuity especially after the use of ICG or TB,[@b3-opth-10-1435]--[@b6-opth-10-1435] resulting in an increasing concern regarding the clinical use of these dyes. Therefore, extensive safety testing of new candidate dyes should be performed before their application in humans.

Acid Violet-17 (AV-17/Coomassie violet R200) is a trityl dye, which exhibits similar chemical properties to BBG. To enhance the staining quality, AV-17 should be applied in a special solvent loaded with heavier water (D~2~O), which leads to a higher density. This dye could stain the anterior capsule of ex vivo porcine eyes and the internal limiting membrane (ILM) satisfactorily, without causing substantial histopathological alterations in the retina.[@b7-opth-10-1435] We have also recently reported that AV-17 was well tolerated at a concentration of up to 0.125 mg/mL in terms of retinal function, survival in the ganglion cell layer, and glial reactivity in isolated bovine retinas.[@b8-opth-10-1435] However, the response of RPE cells is a further critical point, since these cells can also be exposed to the dye during macular hole surgery when the dye migrates through the macular hole into the subretinal space.[@b9-opth-10-1435],[@b10-opth-10-1435] Indeed, several groups reported complications such as RPE atrophy and reduced visual acuity after macular hole surgery using the dyes TB[@b11-opth-10-1435] and ICG.[@b12-opth-10-1435]

In a recent study, the viability of the human RPE cell line ARPE-19 after treatment with various dyes including AV-17 was evaluated, and a 3-minute exposure to AV-17 was reported to be well tolerated at a maximal concentration of 0.05 mg/mL.[@b13-opth-10-1435] Yet, in the case of RPE, the extent of cell differentiation is an equally critical parameter defining the safety of a dye. The RPE tissue comprises a monolayer of highly polarized and differentiated cells, with organelles and cytoskeletal elements localized to distinct subcellular positions.[@b14-opth-10-1435]--[@b16-opth-10-1435] Formation of this differentiated architecture is promoted by the tight and cell--cell (adherens) junctions between adjacent cells. The tight and adherens junctions are further supported by linkage to the actin cytoskeleton via the linker proteins ZO-1 and CTNNB1, respectively. Accordingly, the loss of junctional integrity triggers the dedifferentiation of RPE cells, which would lead to a functional decline.[@b16-opth-10-1435]--[@b18-opth-10-1435] Studies on cultured human[@b19-opth-10-1435] and bovine RPE cells[@b20-opth-10-1435] demonstrated that the exposure to ICG can alter the bioelectrical properties of these cells and induce premature senescence through oxidative stress. Likewise, the exposure of ARPE-19 cells to ICG resulted in morphological alterations suggestive of cytoskeletal rearrangement and a decrease in viability.[@b21-opth-10-1435]

In this study, we explored the safety profile of AV-17 on differentiated RPE cultures by analyzing cell viability. We also evaluated the extent of differentiation with particular emphasis on the organization of the actin cytoskeleton and the integrity of tight and adherens junctions. Furthermore, the levels of KRT19, an intermediate filament associated with dedifferentiated and migrating RPE cells,[@b22-opth-10-1435] were determined.

Methods
=======

Chemicals and reagents
----------------------

Antibodies as well as the major chemicals and reagents used were listed in [Table 1](#t1-opth-10-1435){ref-type="table"}. The remaining chemicals were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) or Carl Roth GmbH + Co. KG (Karlsruhe, Germany).

RPE culture
-----------

Bovine eyes were obtained from a local slaughterhouse and used within 5 hours post-mortem. RPE cells were isolated as described[@b23-opth-10-1435],[@b24-opth-10-1435] with slight modifications. Briefly, the eyes were submerged for 5 minutes in an 11% iodine solution (Betaisodona, Mundipharma GH, Limburg, Germany) followed by rinsing twice with phosphate buffered saline (PBS) for 5 minutes. Eyes were dissected circumferentially 5 mm posterior to the limbus. Afterwards, the anterior segment, vitreous, and retina were discarded. The exposed retinal pigment epithelium was washed three times in PBS to remove the photoreceptor debris. The eyecup was filled with 0.05% trypsin--0.02% ethylenediaminetetraacetic acid solution and incubated for 75 minutes at 37°C. Dissociated RPE cells were collected using a Pasteur pipette avoiding injury to the Bruch's membrane and pooled from 5 to 6 eyes. Cells were transferred into the culture medium (Dulbecco's Modified Eagle's Medium/F12 supplemented with 10% fetal bovine serum, 2 mM [l]{.smallcaps}-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin), centrifuged at 300 ×*g* for 8 minutes, and resuspended in fresh culture medium. Cells were seeded either into a 75 cm^2^ culture flask or culture plates (six-well plate, 24-well fluorocarbon plate; Zell-Kontakt GmbH, Nörten-Hardenberg, Germany) and maintained in a humidified 37°C incubator with 5% CO~2~. After reaching confluence (1--2 weeks), cells in the flasks were subcultured further with trypsin--ethylenediaminetetraacetic acid treatment and seeded into six-, 24-, or 96-well plates.

To achieve an in vitro setting that resembles the normal differentiated cells in situ, we initially optimized the culture conditions of RPE cells. For this purpose, confluent primary and subcultured RPE cells (passages 3--7) in the culture plates were maintained in a low- (2% v/v) serum medium for 8--16 weeks, with the replenishment of culture medium by one half every 2--3 days. The extent of cellular junction formation and differentiation was evaluated by performing immunofluorescence staining for ZO-1, CTNNB1, and KRT19 as described later, and the results are demonstrated in [Figure 1](#f1-opth-10-1435){ref-type="fig"}.

Treatment with AV-17
--------------------

AV-17 was dissolved at concentrations between 0.0625 and 0.5 mg/mL in the solvent, sterile filtered, and stored at 4°C until use. The culture medium was removed completely from the RPE cells grown in the six-, 24-, or 96-well plates, and the wells were filled immediately with the dye solution or solvent (100 µL/well in the 96-well plates, 250 µL/well in the 24-well plates, and 1 mL/well in the six-well plates). As control, a group of cells were treated with low-serum medium in the same manner. After incubation of 30 seconds or 5 minutes under ambient light, the solutions were discarded, the cells were washed three times for 5 minutes in PBS at the aforementioned volumes, and allowed to recover in low-serum medium overnight at 37°C with 5% CO~2~ in dark. As additional controls, a group of cells treated with low-serum medium were incubated overnight in medium supplemented with 10 ng/mL TGFbeta-2 to stimulate dedifferentiation or in PBS with 600 µM H~2~O~2~ to induce cell injury.

Live/dead staining
------------------

Culture medium was aspirated gently, the cells were rinsed briefly with 0.1% glucose--PBS, and incubated for 15 minutes in 2 µM ethidium homodimer-1 and 2 µM calcein-AM (Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA) diluted in 0.1% glucose--PBS under protection from light. Cells were then fixed, permeabilized, counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (1 µg/mL in PBS), mounted in Mowiol as previously described,[@b25-opth-10-1435] and analyzed by fluorescence microscopy (Leica Microsystems, Wetzlar, Germany). Images of all the subgroups of a given experiment were acquired on the same day using a monochrome digital camera (DFC 350 FX; Leica Microsystems) attached to the microscope and the Leica Application Software (Advanced Fluorescence 2.3.0, build 5131) under identical settings for exposure time, gain, and intensity. Quantification of the staining intensity was performed using the ImageJ software (National Institutes of Health, Bethesda, MD, USA, <http://imagej.nih.gov/ij/>, 1997--2014) on the images having an area of 0.04 mm^2^. The viability index was calculated from the ratio of the intensities of calcein and ethidium homodimer-1 stainings.

MTT test
--------

Bovine RPE cells at passages 3--7 were seeded into the inner wells of 96-well culture plates at a density of 5,000 cells/well, with six wells for each treatment group, and allowed to differentiate for 8--10 weeks. Cells were treated with the test substances and allowed to recover overnight as described. An additional group of cells were left untreated as normal controls. MTT test was performed on the following day as described.[@b25-opth-10-1435] The absorbance values at 544 nm were read using a spectrophotometric plate reader (FLUOstar, BMG Labtech GmbH, Ortenberg, Germany). The background values of the negative control were subtracted from the absorbance values of all the test groups. For each test group, the average absorbance value was calculated from the readings in the corresponding six wells after background subtraction. Data are presented as the mean ± standard error of mean (SEM) of n=3 independent tests.

Immunofluorescence staining
---------------------------

Cells grown in 24-well fluorocarbon plates with excisable foil-bottoms (Zell-Kontakt GmbH, Nörten-Hardenberg, Germany) were fixed in 2% paraformaldehyde--PBS for 10 minutes followed by 4% paraformaldehyde--PBS for 10 minutes, rinsed three times in PBS, and incubated with the blocking buffer (3% BSA--PBS with 0.3% Triton X-100) for 30 minutes. Primary and secondary antibodies were diluted in the blocking buffer as indicated in [Table 1](#t1-opth-10-1435){ref-type="table"}. Cells were incubated with the primary antibodies overnight at 4°C followed by secondary antibodies for 1 hour at room temperature protected from light. Actin filaments were stained with Alexa 488-phalloidin (240 units/mL in blocking buffer) for 30 minutes, and the nuclei were counterstained with DAPI (1 µg/mL in PBS) for 10 minutes, with the cells being washed three times in PBS after each step. The well bottom was excised using a scalpel and placed flatly onto a drop of PBS pipetted onto a microscope slide (25 µL/foil) with the cell-seeded side facing upward. Cells were mounted in Mowiol, stored at 4°C, and examined under a fluorescence microscope (Leica Microsystems). Images were acquired as described in the live/dead staining section.

Quantification of the staining intensity was performed using the ImageJ software on the images with an area of 0.04 mm^2^ by marking all the cells that lie completely in the field of view. Intensity of junctional ZO-1 and CTNNB1 was determined from the ratio of the intensity at the cell perimeter to the mean cytoplasmic intensity. To better identify the boundaries of cells that exhibit a very weak staining, the intensities of cleaved CASP3 and KRT19 stainings were quantified on the merged images, by using the DAPI and actin filament stainings, respectively, for cell identification and recording the green intensity values from the histograms of marked regions. The mean intensity of negative controls (incubated with the blocking buffer alone without the primary antibody) were subtracted from the intensity of test groups for all the immunostainings.

Statistical analysis
--------------------

The data were analyzed by two-sided Student's *t*-test assuming equal variance among the samples and the *P*-values \<0.05 were considered as significant. Data are presented either as mean ± standard deviation (SD) of a representative set of experiments or mean ± SEM of n=3 independent experiments.

Results
=======

Viability of the primary and subcultured RPE cells in response to AV-17
-----------------------------------------------------------------------

Viability of the differentiated RPE cells after exposure to AV-17 was evaluated by the live/dead assay, extent of CASP3 cleavage, and the MTT test, which all reflect different parameters. The live/dead assay employs the vital dye calcein, which emits green fluorescence after being processed by esterases in living cells and the red fluorescent nucleic acid dye ethidium homodimer-1, which cannot penetrate intact cell membranes.

In the primary RPE cells, the 30-second exposure to the solvent or AV-17 (0.125 and 0.25 mg/mL) did not result in remarkable toxicity, as demonstrated by the strong cytoplasmic staining with calcein and the negligible ethidium homodimer-1 uptake. Though the cells exposed to 0.5 mg/mL AV-17 exhibited lower calcein staining, there was no significant increase in the uptake of ethidium homodimer-1 ([Figure 2A](#f2-opth-10-1435){ref-type="fig"}). Following the 5-minute exposure, cells treated with the solvent or 0.125 mg/mL AV-17 also exhibited a high degree of viability. However, the cells exposed to 0.25 and 0.5 mg/mL dye demonstrated lower levels of calcein staining or a gradual increase in the uptake of ethidium homodimer-1, resulting in a significant decrease of 36%--38% in the viability score calculated from the ratio of calcein to ethidium homodimer-1 intensity (*P*=0.0058 and *P*=0.0009, respectively compared to the cells treated with medium, mean ± SD of n=4--7 images of 0.04 mm^2^ from a representative experiment, [Figure 2B and C](#f2-opth-10-1435){ref-type="fig"}).

Treatment of subcultured RPE cells with AV-17 yielded similar results as the primary cells. The 5-minute exposure to the solvent or 0.125 mg/mL AV-17 was well tolerated, whereas the cells treated with 0.25 and 0.5 mg/mL AV-17 exhibited gradually lower levels of calcein with a slight, dose-dependent increase in ethidium homodimer-1 uptake. The viability score was reduced by 43% in the subcultured RPE cells treated with 0.5 mg/mL AV-17 (*P*=0.0075 compared to the cells treated with medium, mean ± SEM of n=3 independent experiments, [Figure 2D](#f2-opth-10-1435){ref-type="fig"}).

To determine the extent of apoptosis, we performed immunostainings for cleaved CASP3 on the primary and subcultured RPE cells. The former group of cells treated with the solvent or 0.125 mg/mL AV-17 exhibited a very weak staining after both the 30-second and 5-minute exposures. However, a significant increase by \~25% was observed in the levels of cleaved CASP3 in the cells exposed to 0.25 and 0.5 mg/mL AV-17 for 5 minutes (*P*=0.0032 and *P*=0.0381, respectively, mean ± SD of n=6--7 images of 0.04 mm^2^). In the subcultured RPE cells, a significant increase in cleaved CASP3 intensity was detected only in the groups treated with 0.5 mg/mL AV-17 for 5 minutes (*P*\<0.0001 compared to the cells treated with medium, mean ± SD of n=10 images of 0.04 mm^2^, [Figure 3](#f3-opth-10-1435){ref-type="fig"}).

We also analyzed viability by performing MTT test on the subcultured and differentiated RPE cells. Interestingly, the 30-second exposure resulted in a slight but insignificant decrease of \~18% in the absorbance values in response to 0.125 and 0.25 mg/mL AV-17 (*P*=0.1322 and *P*=0.0769, respectively; mean ± SEM of n=3 independent experiments). A significant reduction of 28% was observed in the absorbance values of cells treated with 0.05 mg/mL AV-17 (*P*=0.0416; mean ± SEM of n=3 independent experiments). Exposure to 0.0625 mg/mL AV-17 or the solvent alone did not result in a significant difference compared to the medium-treated cells ([Figure 4](#f4-opth-10-1435){ref-type="fig"}).

Organization of the actin cytoskeleton after exposure to AV-17
--------------------------------------------------------------

The control group of primary RPE cells treated with low-serum medium exhibited a hexagonal morphology with circumferential actin filaments. In contrast, the dedifferentiated control cells incubated with 10 ng/mL TGFbeta-2 exhibited a morphology dominated by fibroblasts and abundant stress fibers. The 30-second exposure to the solvent or dye did not result in a remarkable difference in cellular morphology or the organization of the actin cytoskeleton that would suggest dedifferentiation. After the 5-minute exposure, the polygonal morphology and the circumferentially arranged actin filaments were maintained in the cells treated with the solvent and 0.125 mg/mL AV-17. However, with increasing concentrations of the dye, the actin filaments became less restricted to the cell--cell borders ([Figure 5](#f5-opth-10-1435){ref-type="fig"}).

Extent of differentiation in the RPE cells after exposure to AV-17
------------------------------------------------------------------

The integrity of the tight and adherens junctions was examined by performing immunostainings for ZO-1 and CTNNB1, respectively. After the 5-minute exposure to the solvent or 0.125 mg/mL AV-17, expression of both proteins at the cellular junctions was well preserved in the primary RPE cells. However, the incubation with 0.25 and 0.5 mg/mL AV-17 resulted in an \~15%--25% decrease in the ratio of junctional to cytoplasmic ZO-1 (*P*\<0.0001, mean ± SEM of n=6--12 images) and a 14.5% increase in cytoplasmic CTNNB1, respectively (*P*=0.0001, mean ± SEM of n=11--18 images of 0.04 mm^2^, [Figure 6](#f6-opth-10-1435){ref-type="fig"}).

Likewise, in the subcultured RPE cells treated with the solvent or 0.125 mg/mL AV-17 for 5 minutes, CTNNB1 was primarily localized to the cell--cell junctions with very little cytoplasmic or nuclear staining. However, exposure to 0.25 and 0.5 mg/mL AV-17 resulted in a significant decrease of 25%--33% in the ratios of junctional to cytoplasmic CTNNB1, respectively (*P*\<0.0001, mean ± SD of n=9--12 images of 0.04 mm^2^, [Figure 7A and B](#f7-opth-10-1435){ref-type="fig"}).

In the differentiated primary RPE cells, we did not detect any immunoreactivity for the intermediate filament KRT19 in any of the treatment groups (data not shown). KRT19 was also expressed at very low levels in the subcultured RPE cells treated with the normal medium, solvent or 0.125 mg/mL AV-17 for 5 minutes. However, the cells exposed to 0.25 and 0.5 mg/mL of AV-17 exhibited a gradual and significant increase in KRT19 expression by 35% and 56%, respectively (*P*=0.0095 and *P*=0.0071, respectively; mean ± SEM of n=3 independent experiments, [Figure 7A and C](#f7-opth-10-1435){ref-type="fig"}).

Discussion
==========

In this study, we evaluated the viability and differentiation of bovine RPE cells after exposure to the vital dye AV-17. Cultures of bovine RPE cells were preferred since these cells can be isolated from post-mortem eyes with a high yield and differentiated in vitro. Bovine RPE cells therefore provide an easily available and cost-effective alternative, which does not entail ethical issues, unlike the establishment of human RPE cultures. The differentiated bovine cells are also expected to simulate the in vivo conditions better than the transformed human RPE cell line ARPE-19, which was found to be relatively robust to different treatments.[@b21-opth-10-1435]

To enable differentiation, we initially allowed the bovine RPE cells to reach confluence for the formation of cellular junctions. Afterward, serum concentration was gradually lowered from 10% to 2% to prevent the overgrowth of cells.[@b26-opth-10-1435] These conditions induced the differentiation of both the primary and the subcultured RPE cells satisfactorily in our study. Both cell types exhibited a similar degree of sensitivity to AV-17 as evaluated by the live/dead assay. The subcultured bovine RPE cells can therefore serve as a flexible alternative to primary RPE cells for viability studies. However, the extent of differentiation was more compromised in the subcultured RPE cells after dye treatment, as determined by the upregulation of KRT19. Expression of the tight junction protein ZO-1 also remained weak in most of the subcultured RPE cells (data not shown), suggesting that the establishment of tight junctions requires a longer period after cell detachment and reattachment, possibly due to the loss of junctional components from the membrane after protease treatment. For evaluating the differentiation state of RPE cells in response to dye exposure, we therefore recommend the use of primary RPE cells to simulate the normal in vivo conditions. However, the subcultured RPE cells may also provide valuable information on the response of already slightly compromised RPE cells in a pathological environment.

In this study, RPE cells were incubated for 30 seconds and 5 minutes with different concentrations of the dye. These time periods were selected to simulate the surgical conditions during which the dye is applied. Our results demonstrated that the exposure to 0.125 mg/mL AV-17 or solvent for 30 seconds and 5 minutes did not result in any signs of toxicity as determined by the live/dead assay and CASP3 cleavage. However, the MTT assay demonstrated a slight decrease of \~18% in mitochondrial activity after a 30-second exposure to 0.125 and 0.25 mg/mL AV-17. This decrease became significant with 0.5 mg/mL of the dye, whereas only the exposure to 0.0625 mg/mL AV-17 or solvent appeared to be well tolerated according to the MTT assay. Our findings were consistent with the results of a former study on ARPE-19 cells, which demonstrated a significant decrease of \~25% in the absorbance values determined by the MTT test after 3-minute exposure to 0.25 and 0.5 mg/mL AV-17. Likewise, the dye at the concentrations of 0.05 and 0.005 mg/mL were well tolerated, with a reduction of \<5% in the absorbance values.[@b13-opth-10-1435] Interestingly, other groups evaluating the biocompatibility of vital dyes also reported more damage with the MTT assay than was seen with light and electron microscopy, suggesting that the dyes may have a greater effect on mitochondrial function.[@b27-opth-10-1435]--[@b29-opth-10-1435] However, the remnants of the dye could also have interfered with the MTT assay, resulting in a dose-dependent reduction in the absorbance values.

We have previously demonstrated that the 5-minute exposure to 0.125 mg/mL AV-17 or the solvent was well tolerated in bovine retinal cells.[@b8-opth-10-1435] Here, we report that the exposure to AV-17 at higher concentrations not only reduces viability but also triggers the dedifferentiation of RPE cells by compromising the integrity of cellular junctions and the organization of actin cytoskeleton. Our findings are also mainly in accordance with the results of a previous study on the retinal biocompatibility of AV-17, which was reported to be superior to TB and ICG. However, contrary to our findings, good biocompatibility was stated even for the concentration of 0.5 mg/mL.[@b7-opth-10-1435] In the former study, the dye was applied into the vitreous humor. The discrepancy between the results might therefore have resulted from the protective effects of the vitreous humor, which was described in detail for the drug triamcinolone.[@b30-opth-10-1435]--[@b32-opth-10-1435]

AV-17 belongs to the same group of substances, the trityl dyes, such as BBG and PB. Therefore, the staining of ILM at the suggested concentrations could be applicable. A recent study demonstrated that 3-minute exposure of vitrectomized cadaveric eyes to 0.05 mg/mL of AV-17 enabled the distinction of ILM from the underlying retina with a high degree of contrast and facilitated the surgical peeling of ILM.[@b13-opth-10-1435] The efficacy of AV-17 to stain ILM at this low concentration together with our findings therefore underline the potential of AV-17 as a novel alternative for vital dyes in vitreoretinal surgery.

Conclusion
==========

The application of AV-17 at a concentration under 0.125 mg/mL in a D~2~O-carrying solvent appears safe for intraocular administration and RPE changes or atrophy are unlikely to occur in case AV-17 migrates into the subretinal space. Nevertheless, similar to the intraocular application of BBG, restricting the time the retina is exposed to this dye would be recommended to avoid adverse effects. The in vivo staining characteristics and acceptance of a new formulation of AV-17/D~2~O in clinical practice also need to be established.
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![Optimization of the culture conditions.\
**Notes:** (**A**) Incubation of confluent primary RPE cells in a low-serum (2% v/v) medium for at least 8 weeks promoted cell differentiation as demonstrated by the expression of the tight junction protein ZO-1 and the adherens junction protein CTNNB1 at cell--cell boundaries. The actin cytoskeleton was also arranged circumferentially underneath the plasma membrane. (**B**) Long-term incubation of subcultured RPE cells in low-serum medium also induced differentiation, as demonstrated by the translocation of CTNNB1 from the cytoplasm to underneath the plasma membrane, and the considerable decrease in the expression of KRT19 in contrast to the cells in high-serum (10% v/v) medium. Scale bars =25 µm.\
**Abbreviations:** RPE, retinal pigment epithelial; DAPI, 4′,6-diamidino-2-phenylindole.](opth-10-1435Fig1){#f1-opth-10-1435}

![Live/dead assay demonstrating the time and dose-dependent viability of RPE cells after exposure to AV-17.\
**Notes:** Primary RPE cells exposed to the solvent or 0.125 mg/mL AV-17 for (**A**) 30 seconds and (**B**) 5 minutes exhibited a high degree of viability, demonstrated by the strong levels of calcein staining and very low levels of ethidium homodimer-1 (EH) uptake, similar to the control group treated with culture medium. In contrast, a decrease in calcein intensity and increase in EH uptake were detected after exposure to higher concentrations. Cells incubated in 600 µM H~2~O~2~ were included as positive controls for EH staining. The nuclei were counterstained with DAPI. Scale bar =25 µm. (**C**) Viability score of the primary RPE cells after exposure to AV-17 or solvent for 5 minutes, calculated from the ratio of the intensity of calcein staining to the intensity of EH uptake. Quantification was performed in n=4--7 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=32 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium. (**D**) Subcultured RPE cells exhibited a similar response to the primary RPE cells after exposure to the solvent or AV-17 at the tested concentrations for 5 minutes, as demonstrated by the viability scores (mean ± SEM of n=3 independent experiments, with a minimum of n=68 cells quantified per group). *P*-values were compared to the control group in culture medium.\
**Abbreviations:** RPE, retinal pigment epithelial; DAPI, 4′,6-diamidino-2-phenylindole; AV-17, Acid Violet-17; SEM, standard error of mean.](opth-10-1435Fig2){#f2-opth-10-1435}

![Extent of CASP3 cleavage demonstrating the time and dose-dependent apoptotic activity after exposure to AV-17.\
**Notes:** A very low level of CASP3 cleavage was detected in the subcultured RPE cells exposed to the solvent or lower concentrations of AV-17 for (**A**) 30 seconds and (**B**) 5 minutes, similar to the control group treated with culture medium. However, the exposure to 0.5 mg/mL resulted in an increase in the levels of cleaved CASP3 immunostaining, which became more prominent after 5-minute exposure. Cells incubated in 600 µM H~2~O~2~ were included as positive controls for the immunostaining. Cells incubated in the blocking buffer alone without the primary antibody served as negative controls. The nuclei were counterstained with DAPI. Scale bar =25 µm. (**C**) Intensity of the cleaved CASP3 immunostaining after the treatment of primary RPE cells for 5 minutes. Quantification was performed in n=6--10 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=79 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium. (**D**) Intensity of the cleaved CASP3 immunostaining after treating the subcultured RPE cells for 5 minutes. Quantification was performed in n=8--16 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=57 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium.\
**Abbreviations:** RPE, retinal pigment epithelial; DAPI, 4′,6-diamidino-2-phenylindole; AV-17, Acid Violet-17.](opth-10-1435Fig3){#f3-opth-10-1435}

![MTT assay demonstrating the extent of RPE viability in terms of metabolic activity.\
**Notes:** Subcultured and differentiated RPE cells exposed to the solvent or 0.0625 mg/mL AV-17 for 30 seconds exhibited a similar degree of viability as the cells treated with medium. However, a gradual decrease was observed in the absorbance values after exposure to increasing concentrations of AV-17, which became significant at 0.5 mg/mL AV-17 (*P*-value compared to the cells treated with medium). A group of cells were left untreated to ensure that the removal of the medium and the subsequent washing steps did not result in cell loss. Data represent the mean ± SEM of n=3 independent experiments.\
**Abbreviations:** RPE, retinal pigment epithelial; AV-17, Acid Violet-17; SEM, standard error of mean.](opth-10-1435Fig4){#f4-opth-10-1435}

![Organization of the actin cytoskeleton in primary RPE cells determined by Alexa 488-phalloidin staining.\
**Notes:** Cells (12 weeks of differentiation) exposed to the solvent or 0.125 mg/mL AV-17 for (**A**) 30 seconds and (**B**) 5 minutes exhibited a polygonal morphology, with the actin filaments organized mainly as circumferential bundles underneath the plasma membrane, similar to the differentiated cells in the control group treated with medium only. However, the 5-minute exposure to 0.25 and 0.5 mg/mL AV-17 resulted in the slight reorganization of the actin cytoskeleton, with the formation of some stress fibers in the cytoplasm. A group of cells incubated with 10 ng/mL TGFbeta-2 were included as controls for the dedifferentiated cells. Scale bar =25 µm.\
**Abbreviations:** RPE, retinal pigment epithelial; AV-17, Acid Violet-17; DAPI, 4′,6-diamidino-2-phenylindole.](opth-10-1435Fig5){#f5-opth-10-1435}

![Integrity of the tight and adherens junctions in the primary RPE cells after exposure to AV-17.\
**Notes:** Exposure of cells (12 weeks of differentiation) to 0.5 mg/mL AV-17 for 5 minutes compromised the integrity of both the tight (**A**) and adherens junctions (**B**), as determined by the ZO-1 and CTNNB1 immunostainings, respectively. These structures and the hexagonal morphology were well preserved in the cells exposed to 0.125 mg/mL AV-17 or the solvent. Scale bar =25 µm. (**C**) Quantification of the integrity of tight junctions, as determined from the ratio of the ZO-1 immunostaining at the cell--cell boundaries to the intensity of the cytoplasmic ZO-1 staining. Quantification was performed in n=6--15 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=44 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium. (**D**) Quantification of the cytoplasmic CTNNB1 immunostaining in n=11--18 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=107 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium.\
**Abbreviations:** RPE, retinal pigment epithelial; AV-17, Acid Violet-17; DAPI, 4′,6-diamidino-2-phenylindole.](opth-10-1435Fig6){#f6-opth-10-1435}

![Expression of CTNNB1 and KRT19 in the subcultured RPE cells.\
**Notes:** (**A**) Exposure of cells (passage 4, 12 weeks in low-serum medium) to 0.25 and 0.5 mg/mL AV-17 for 5 minutes compromised the integrity of the adherens junctions, as detected by the increase in the cytoplasmic and nuclear expression of CTNNB1. In contrast, CTNNB1 was mainly localized underneath the plasma membrane in the cells exposed to 0.125 mg/mL AV-17 or the solvent, similar to the control cells treated with medium. Likewise, the expression of KRT19 underwent a gradual and dose-dependent increase in the cells exposed to 0.25 and 0.5 mg/mL AV-17 for 5 minutes. Scale bars =25 µm. (**B**) Quantification of the integrity of the adherens junctions, as determined from the ratio of the CTNNB1 immunostaining at the cell--cell boundaries to the intensity of the cytoplasmic CTNNB1 staining. Quantification was performed in n=9--18 images of 0.04 mm^2^ of a representative set of experiments, with a minimum of n=48 cells per group. The experiments were repeated three times. *P*-values were compared to the control group treated in culture medium. (**C**) Quantification of the KRT19 expression in cytoplasm. Data represent the mean ± SEM of n=3 independent experiments, with the quantification of a minimum of n=116 cells per group. *P*-values were compared to the control group treated in culture medium.\
**Abbreviations:** RPE, retinal pigment epithelial; AV-17, Acid Violet-17; SEM, standard error of mean; DAPI, 4′,6-diamidino-2-phenylindole.](opth-10-1435Fig7){#f7-opth-10-1435}

###### 

Chemicals, reagents, and antibodies used

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Chemicals and reagents                                                                                                                                                                                                                                                  
  -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ------------ ----------------------------------------------------------------- -------------------- ---------------------
  AV-17                                                                                              Fluoron GmbH (Neu-Ulm, Germany)                                  --                                                                                                  

  AV-17 solvent (0.13 mL D~2~O, 1.9 mg Na~2~HPO~4~, 0.3 mg NaH~2~PO~4~, 8.2 mg NaCl in 1 mL H~2~O)   Fluoron GmbH                                                     --                                                                                                  

  Phosphate buffered saline                                                                          Life Technologies (Thermo Fisher Scientific, Waltham, MA, USA)   14190-169                                                                                           

  Dulbecco's Modified Eagle's Medium/F-12 (1:1)                                                      Life Technologies (Thermo Fisher Scientific)                     21331-046                                                                                           

  Fetal bovine serum, heat-inactivated                                                               Life Technologies (Thermo Fisher Scientific)                     10082-147                                                                                           

  Glutamine/Penicillin/Streptomycin mixture                                                          Life Technologies (Thermo Fisher Scientific)                     10378-016                                                                                           

  0.05% Trypsin-0.02% EDTA                                                                           Life Technologies (Thermo Fisher Scientific)                     25300-054                                                                                           

  BSA, cell culture grade                                                                            Sigma-Aldrich Co. (St Louis, MO, USA)                            A9418-100G                                                                                          

  TGFbeta-2                                                                                          Reliatech GmbH (Wolfenbüttel, Germany)                           100-105                                                                                             

  Phalloidin, Alexa 488-conjugated                                                                   Molecular Probes (Thermo Fisher Scientific)                      A12379                                                                                              

                                                                                                                                                                                                                                                                          

  **Primary antibodies**                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                          

  **Antigen**                                                                                        **Type**                                                         **Clone**    **Company**                                                       **Catalog number**   **Dilution factor**

                                                                                                                                                                                                                                                                          

  CTNNB1                                                                                             Rabbit IgG, monoclonal                                           E247         Epitomics, Biomol (Hamburg, Germany)                              1247-1               1/250

  Cleaved\                                                                                           Rabbit IgG, monoclonal                                           E83-77       Epitomics, Biomol                                                 1476-1               1/100
  CASP3                                                                                                                                                                                                                                                                   

  KRT19                                                                                              Mouse IgG, monoclonal                                            RCK108       Dako Denmark A/S, (Glostrup, Denmark)                             M088801-2            1/50

  ZO-1                                                                                               Rabbit IgG, polyclonal                                           --           Abcam (Cambridge, UK)                                             ab59720              1/50

                                                                                                                                                                                                                                                                          

  **Secondary antibodies**                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                          

  **Reactivity**                                                                                     **Type**                                                         **Label**    **Company**                                                       **Catalog number**   **Dilution factor**

                                                                                                                                                                                                                                                                          

  Mouse IgG                                                                                          Goat IgG (H+L)                                                   Alexa 546    Molecular Probes (Thermo Fisher Scientific)                       A-11003              1/100

  Rabbit IgG                                                                                         Goat IgG (H+L)                                                   Cy3          Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA, USA)   111-165-003          1/200
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AV-17, Acid Violet-17; EDTA, ethylenediaminetetraacetic acid; IgG, immunoglobulin G; H+L, heavy and light chains.
